CN Menu
Press Release
Awarded "EY Fudan Most Potential Enterprise" in 2022, Evergreen's Business Model and Development Potential Recognized by Authority
Source:Evergreen Date: Sep,2022 Views: 813

On September 15, 2022, the "Ernst & Young Fudan Most Potential Enterprise Award Ceremony 2022 and High Growth Enterprise Theme Seminar" hosted by Ernst & Young, one of the world's leading professional services networks, and the School of Management of Fudan University, a top university in China, kicked off in Shanghai. The "EY Fudan Most Potential Enterprises" awardees which has attracted much attention from different industries was officially announced. After authoritative, professional, and strict screening, Evergreen Therapeutics – with its reliance on the core founding and management team composed of FDA reviewers and the industry's top clinical research and development and AI/quantum technology teams with decades of experience in new drug research and development, its R&D and business models as well as high-speed pipeline R&D progress – was one of the companies that stood out and won the "Ernst & Young Fudan Most Potential Enterprise Award".